December 24, 2018 by Chain Drug Review
Cigna Corp., Cigna-Express Scripts merger, David Cordani, Express Scripts Holding Co.
Business, Leading Headlines, Pharmacy
BLOOMFIELD, Conn. — Cigna Corp. has successfully completed its combination with Express Scripts Holding Company effective December 20, 2018. Consistent with its commitment to support local communities and improve societal health, Cigna also announced an incremental investment of $200 million to its charitable foundation and communities and is launching Healthier Kids for Our Future, a
September 5, 2018 by Chain Drug Review
Aetna Inc., Cigna-Express Scripts merger, CVS Health, Express Scripts Holding Co.
Featured Articles, Leading Headlines, Retail News
WASHINGTON — CVS Health Corp.’s planned acquisition of Aetna Inc. is close to getting the official go-ahead from federal regulators, according to a report published Wednesday by The Wall Street Journal, which said the deal could receive formal antitrust approval from the U.S. Department of Justice within the next few weeks. That approval is expected to
March 19, 2018 by Chain Drug Review
B. Douglas Hoey, Cigna, Cigna-Express Scripts merger, CVS-Aetna merger, David Cordani, Express Scripts, Tim Wentworth
2018, Issue 03-19-2018, Issues, News
BLOOMFIELD, Conn. — Another blockbuster merger is adding momentum to the consolidation wave sweeping through the health care sector, and again crossing industry segments. Health insurer Cigna Corp. plans to acquire pharmacy benefits manager Express Scripts in a $67 billion cash and stock deal. Under the agreement, unveiled earlier this month, Cigna will pay Express
March 8, 2018 by Chain Drug Review
Aetna, Cigna, Cigna-Express Scripts merger, CVS Health, CVS-Aetna merger, David Cordani, Express Scripts, Tim Wentworth
Business, Featured Articles, Leading Headlines, Pharmacy, Retail News
BLOOMFIELD, Conn., and ST. LOUIS — Continuing cross-segment consolidation in the health care arena, health insurer Cigna Corp. plans to acquire pharmacy benefits manager Express Scripts in a $67 billion cash and stock deal. The companies said Thursday that, under the Cigna-Express Scripts merger agreement, Cigna will pay Express Scripts shareholders $48.75 in cash and 0.2434